Root Privileges

Tag: Bharat Biotech

  • On Agnihotri’s Covaxin film, defamation, and false bravery

    On Agnihotri’s Covaxin film, defamation, and false bravery

    —

    by

    VM
    in , ,

    Vivek Agnihotri’s next film, The Vaccine War, is set to be released on September 28. It is purportedly about the making of Covaxin, the COVID-19 vaccine made by Bharat Biotech, and claims to be based on real events. Based on watching the film’s trailer and snippets shared on Twitter, I can confidently state that while…

  • The biopolitics of Covaxin

    The biopolitics of Covaxin

    —

    by

    VM
    in , ,

    In a new investigation, STAT has reported fresh problems with Covaxin’s approval process in India, including the phase 2 trial dropping its placebo arm in favour of one preordained to make Covaxin look good and Bharat Biotech – the maker – commencing phase 3 trials based on results from animal studies. I’m also filing the report…

  • About vaccines for children and Covaxin…

    —

    by

    VM
    in ,

    I don’t understand his penchant for late-night announcements, much less one at 10 pm on Christmas night, but Prime Minister Narendra has just said the government will roll out vaccines for young adults aged 15-18 years from January 3, 2022 – around the same time I received a press release from Bharat Biotech saying the…

  • The toxic affair between Covaxin and The Lancet

    —

    by

    VM
    in ,

    That Covaxin has been leading a ceaselessly beleaguered life is no mystery – but The Lancet journal may not know that it has been pressed into the questionable service of saving the vaccine’s reputation on at least three occasions. In the latest one, for example, Bharat Biotech, some clueless media outlets and their hordes of…

  • Is Covaxin’s WHO approval guaranteed?

    —

    by

    VM
    in ,

    I suspect after reading this PTI report that the WHO is practically helping Bharat Biotech put together a better application to have its COVID-19 vaccine, Covaxin, get the body’s approval for international use, instead of simply considering what Bharat Biotech chooses to submit. The overall tone of the report is mollificatory – as if the…

  • It’s great that the WHO isn’t just ‘not cutting corners’

    —

    by

    VM
    in

    Call me anti-national (and I’m sure many will) but I’m glad that the WHO isn’t just “not cutting corners” in the process of considering Bharat Biotech’s application for the UN body’s stamp of approval Covaxin but is also openly calling for more and more information from the company at periodic intervals. This isn’t just a…

  • Bharat Biotech gets 1/10 for tweet

    —

    by

    VM
    in

    If I had been Bharat Biotech’s teacher and “Where is your data?” had been an examination question, Bharat Biotech would have received 1 out of 10 marks. The correct answer to where is your data can take one of two forms: either an update in the form of where the data is in the data-processing…

  • India’s missing research papers

    —

    by

    VM
    in

    If you’re looking for a quantification (although you shouldn’t) of the extent to which science is being conducted by press releases in India at the moment, consider the following list of studies. The papers for none of them have been published – as preprints or ‘post-prints’ – even as the people behind them, including many…